查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1784158

空间体学的全球市场

Spatial OMICS
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 228 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球空间体学市场规模将达到 20 亿美元

全球空间体学市场规模预计在2024年达到7.677亿美元，预计在2024-2030年的分析期内将以17.5%的复合年增长率增长，到2030年将达到20亿美元。空间转录组学是本报告分析的细分领域之一，预计其复合年增长率将达到19.1%，到分析期结束时规模将达到13亿美元。空间基因组学细分领域在分析期间的复合年增长率预计为14.8%。

美国市场规模估计为 2.018 亿美元，中国市场预计复合年增长率为 16.5%

美国的空间体学市场规模预计在2024年达到2.018亿美元。预计在分析期内（2024-2030年），全球第二大经济体中国的空间组学市场复合年增长率将达到16.5%，到2030年市场规模将达到3.104亿美元。其他值得关注的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为16.4%和15.0%。在欧洲，预计德国的复合年增长率约为12.7%。

全球空间体学市场—主要趋势与驱动因素摘要

为什么空间体学改变分子和细胞生物学的未来？

空间体学正迅速崛起，成为生命科学和生物医学研究中的一股变革力量，它提供了前所未有的能力，能够在分子活动的原生空间环境中进行绘製。透过将高解析度成像、转录组学、蛋白质组学和代谢体学与空间资讯结合，研究人员如今可以研究基因表现和蛋白质相互作用在不同组织结构和微环境中的变化。这种整合方法与缺乏空间定位的批量定序和单细胞定序截然不同。空间体学使科学家能够揭示组织异质性、疾病进展和细胞间通讯的复杂性。随着研究人员不仅寻求了解哪些基因表达，还寻求了解它们在组织基质中的位置和相互作用方式，空间组学在肿瘤学、神经科学、免疫学和发育生物学中的应用正在迅速扩展。尤其是在癌症研究中，空间体学有助于描绘肿瘤边缘、追踪免疫细胞浸润，并识别影响疗效的微环境微环境。随着生命科学进一步走向精准医疗，空间体学成为标靶治疗、生物标记发现和下一代诊断的关键推动因素。

科技创新如何提高空间体学的解析度和可近性？

空间体学领域受到成像平台、分子标记、条码策略和数据分析的快速创新所驱动。结合萤光杂合反应(FISH)、免疫组织化学和次世代定序的高通量平台如今能够同时可视化单一组织切片中数百至数千个 RNA 转录物和蛋白质。空间转录组学、多重离子束成像 (MIBI)、seqFISH 和 CODEX 等技术为研究人员提供了涵盖二维和三维组织图谱的可扩展解决方案。新的化学主导工作流程能够以更高的灵敏度检测低丰度分子，而先进的微流体和奈米製造技术正在将空间分辨率提升至亚细胞水平。人工智慧和机器学习在复杂空间资料集的分析中也发挥着越来越重要的作用，使得人们能够解读先前过于复杂而难以解开的空间模式和生物分子网路。与表观基因和代谢体学等其他体学层面的整合，进一步拓展了空间分析的深度，为细胞功能、分化和疾病发病机制提供了多维度的洞察。这些技术进步使空间体学更加稳健、可重复且易于使用，使其在实验室和临床环境中被更广泛的受众所接受。

哪里的市场需求成长最快？主要的最终用户是谁？

空间体学技术在学术、製药、生物技术和临床研究领域越来越受到关注。在学术机构，研究人员利用空间分析在单细胞层级研究脑迴路、胚胎发育和组织再生。製药和生物技术公司正在将空间组学应用于药物研发和转化研究，尤其是在肿瘤学领域，了解肿瘤微环境对于开发免疫治疗方法和标靶干预措施至关重要。委外研发机构(CRO) 也将空间体学整合到其生物标记开发平臺中，为寻求空间分辨资料集的客户提供专业服务。医院和诊断实验室开始将空间体学视为病理学和个人化医疗的未来工具，尤其适用于表征罕见疾病和对常规治疗无反应的肿瘤亚型。美国和欧洲对空间组学的需求尤其强劲，这些地区的研究资金和精准医疗计划蓬勃发展，但亚太地区正在迅速赶上，中国、日本和韩国在空间生物学基础设施方面投入了大量资金。私募股权和创业投资对太空体学新兴企业和平台开发人员的投资进一步刺激了创新和商业性扩张，从而使空间体学成为生命科学产业的基础技术。

什么将推动空间体学市场的长期成长？

空间体学市场的成长受到几个关键因素的驱动，这些因素集中在对空间分辨生物数据日益增长的需求、个人化医疗的发展和技术融合方面。最重要的驱动因素之一是人们越来越认识到空间背景对于理解异质性疾病机制至关重要，尤其是在癌症、神经退化和自体免疫疾病中。这种认识刺激了对提供跨各种组织类型和病理的可操作空间资料的工具和平台的投资。定序和成像技术的进步，以及工作流程自动化、可扩展性和多路復用的改进，正在降低成本和复杂性障碍，使其能够在精英研究中心之外得到更广泛的应用。学术界和产业界之间日益增多的合作正在加速空间发现向临床应用的转化，特别是在诊断、伴随生物标记开发和治疗反应监测领域。监管和资助机构也认识到空间体学的潜力，并为其临床整合提供津贴和核准。此外，空间资料集的扩展正在推动空间图谱和多组学资料库的发展，从而增强跨研究比较和机器学习应用。随着各学科对高解析度生物学洞察的需求不断增长，空间体学有望成为下一代生物医学研究和精准医疗的基本支柱。

部分

技术（空间转录组学、空间基因组学、空间蛋白质组学）、产品（仪器、耗材、软体）、工作流程（样品製备、仪器分析、数据分析）、样品类型（FFPE、新鲜冷冻）、最终用户（学术和转化研究机构、製药和生物技术公司）

受访公司范例

  • 10x Genomics
  • Agilent Technologies Inc.
  • Akoya Biosciences Inc.
  • Biognosys AG
  • Bio-Rad Laboratories Inc.
  • BioSpyder Technologies
  • Bio-Techne Corporation
  • Bruker Corporation
  • Curio Bioscience
  • Diagenode Diagnostics
  • Illumina Inc.
  • Indica Labs Inc.
  • IonPath Inc.
  • Luminex Corporation
  • Miltenyi Biotec
  • Miroculus Inc.
  • NanoString Technologies Inc.
  • Oxford Nanopore Technologies
  • PerkinElmer Inc.
  • Pixelgen Technologies
  • RareCyte Inc.
  • Rebus Biosystems
  • S2 Genomics Inc.
  • Seven Bridges Genomics
  • Standard BioTools（formerly Fluidigm）
  • Takara Bio Inc.
  • Ultivue Inc.
  • Visiopharm A/S
  • Vizgen Corporation
  • ZEISS Group

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 没有查询通用的 LLM 或特定产业的SLM，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP33026

Global Spatial OMICS Market to Reach US$2.0 Billion by 2030

The global market for Spatial OMICS estimated at US$767.7 Million in the year 2024, is expected to reach US$2.0 Billion by 2030, growing at a CAGR of 17.5% over the analysis period 2024-2030. Spatial Transcriptomics, one of the segments analyzed in the report, is expected to record a 19.1% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Spatial Genomics segment is estimated at 14.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$201.8 Million While China is Forecast to Grow at 16.5% CAGR

The Spatial OMICS market in the U.S. is estimated at US$201.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$310.4 Million by the year 2030 trailing a CAGR of 16.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.4% and 15.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.7% CAGR.

Global Spatial OMICS Market - Key Trends & Drivers Summarized

Why Is Spatial OMICS Reshaping the Future of Molecular and Cellular Biology?

Spatial OMICS is rapidly emerging as a transformative force in life sciences and biomedical research, offering an unprecedented ability to map molecular activity within its native spatial context. By combining high-resolution imaging, transcriptomics, proteomics, and metabolomics with spatial information, researchers can now investigate how gene expression and protein interactions vary across tissue architecture and microenvironments. This integrated approach is a significant leap beyond bulk and single-cell sequencing, which lack spatial positioning. Spatial OMICS is allowing scientists to unravel the complexities of tissue heterogeneity, disease progression, and cell-to-cell communication with exquisite precision. Applications in oncology, neuroscience, immunology, and developmental biology are rapidly expanding, as researchers aim to understand not just what genes are expressed, but where and how they interact within the tissue matrix. Particularly in cancer research, spatial OMICS is helping to delineate tumor margins, track immune cell infiltration, and identify microenvironmental niches that influence treatment response. As life sciences push further into precision medicine, spatial OMICS stands out as a critical enabler of targeted therapies, biomarker discovery, and next-generation diagnostics.

How Are Technology Innovations Elevating the Resolution and Accessibility of Spatial OMICS?

The field of spatial OMICS is being driven forward by rapid innovation in imaging platforms, molecular labeling, barcoding strategies, and data analytics. High-throughput platforms combining fluorescence in situ hybridization (FISH), immunohistochemistry, and next-generation sequencing are now capable of visualizing hundreds to thousands of RNA transcripts and proteins simultaneously within a single tissue section. Technologies such as spatial transcriptomics, multiplexed ion beam imaging (MIBI), seqFISH, and CODEX are providing researchers with scalable solutions across both 2D and 3D tissue landscapes. New chemistry-driven workflows are making it possible to detect low-abundance molecules with greater sensitivity, while advanced microfluidics and nanofabrication techniques are enhancing spatial resolution down to subcellular levels. AI and machine learning are also playing an increasingly vital role in analyzing complex spatial datasets, enabling the interpretation of spatial patterns and biomolecular networks that were previously too intricate to resolve. Integration with other omics layers-such as epigenomics and metabolomics-is further extending the depth of spatial analysis, providing multi-dimensional insights into cell function, differentiation, and disease pathology. These technical advancements are making spatial OMICS more robust, reproducible, and user-friendly, opening access to a broader segment of research labs and clinical institutions.

Where Is Market Demand Emerging Most Rapidly, and Who Are the Key End Users?

Spatial OMICS technologies are gaining traction across academic, pharmaceutical, biotechnology, and clinical research settings. In academic institutions, researchers are leveraging spatial analysis to study brain circuitry, embryonic development, and tissue regeneration at a single-cell level. Pharmaceutical and biotech companies are deploying spatial OMICS for drug discovery and translational research, particularly in oncology, where understanding the tumor microenvironment is crucial to developing immune-based therapies and targeted interventions. Contract research organizations (CROs) are also integrating spatial OMICS into biomarker development pipelines, offering specialized services for clients pursuing spatially resolved datasets. Hospitals and diagnostic labs are beginning to explore spatial OMICS as a future tool in pathology and personalized medicine, especially for characterizing rare diseases or tumor subtypes that don’t respond to conventional treatments. Demand is particularly high in the United States and Europe, where research funding and precision medicine initiatives are strong, but Asia-Pacific is rapidly catching up, with major investments in spatial biology infrastructure across China, Japan, and South Korea. Private equity and venture capital investment in spatial OMICS startups and platform developers is further fueling innovation and commercial expansion. These converging forces are establishing spatial OMICS as a cornerstone technology across the life sciences landscape.

What’s Driving the Long-term Growth of the Spatial OMICS Market?

The growth in the spatial OMICS market is driven by several critical factors centered around the rising demand for spatially resolved biological data, the evolution of personalized medicine, and technological convergence. One of the foremost drivers is the growing realization that spatial context is essential for understanding disease mechanisms, particularly in heterogeneous conditions such as cancer, neurodegeneration, and autoimmune disorders. This insight is fueling investment in tools and platforms that provide actionable spatial data across various tissue types and disease states. The advancement of sequencing and imaging technologies, along with improvements in workflow automation, scalability, and multiplexing, is reducing cost and complexity barriers, enabling wider adoption beyond elite research centers. Increasing collaborations between academia and industry are accelerating the translation of spatial discoveries into clinical applications, particularly in the realm of diagnostics, companion biomarker development, and therapeutic response monitoring. Regulatory agencies and funding bodies are also recognizing the potential of spatial OMICS, directing grants and approvals toward its clinical integration. Additionally, the expansion of spatial datasets is powering the development of spatial atlases and multi-omic databases that enhance cross-study comparisons and machine learning applications. As the need for high-resolution biological insights continues to rise across disciplines, spatial OMICS is positioned to become a foundational pillar of next-generation biomedical research and precision healthcare.

SCOPE OF STUDY:

The report analyzes the Spatial OMICS market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Spatial Transcriptomics, Spatial Genomics, Spatial Proteomics); Product (Instruments, Consumables, Software); Workflow (Sample Preparation, Instrumental Analysis, Data Analysis); Sample Type (FFPE, Fresh Frozen); End-Use (Academic & Translational Research Institutes, Pharma & Biotech Companies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 36 Featured) -

  • 10x Genomics
  • Agilent Technologies Inc.
  • Akoya Biosciences Inc.
  • Biognosys AG
  • Bio-Rad Laboratories Inc.
  • BioSpyder Technologies
  • Bio-Techne Corporation
  • Bruker Corporation
  • Curio Bioscience
  • Diagenode Diagnostics
  • Illumina Inc.
  • Indica Labs Inc.
  • IonPath Inc.
  • Luminex Corporation
  • Miltenyi Biotec
  • Miroculus Inc.
  • NanoString Technologies Inc.
  • Oxford Nanopore Technologies
  • PerkinElmer Inc.
  • Pixelgen Technologies
  • RareCyte Inc.
  • Rebus Biosystems
  • S2 Genomics Inc.
  • Seven Bridges Genomics
  • Standard BioTools (formerly Fluidigm)
  • Takara Bio Inc.
  • Ultivue Inc.
  • Visiopharm A/S
  • Vizgen Corporation
  • ZEISS Group

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Spatial OMICS - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Explosive Growth in Single-cell Biology Throws the Spotlight on Spatial OMICS as the Next Frontier in Tissue-level Resolution
    • Rising Focus on Tumor Microenvironment Characterization Spurs Adoption of Spatial Transcriptomics in Cancer Research
    • Here's How Precision Medicine Initiatives Expand the Addressable Market for Spatially Resolved Multi-omic Platforms
    • Integration of Spatial Genomics and Proteomics Strengthens the Business Case for Holistic Tissue Analysis Tools
    • Demand for High-resolution Mapping of Cellular Architecture Drives Innovation in Spatial Imaging and Label-free Detection
    • Here's the Story: Spatial OMICS Emerges as a Critical Enabler in Drug Discovery, Target Validation, and Biomarker Development
    • Advancements in In Situ Sequencing and Multiplexed Imaging Propel Growth of Scalable, High-throughput Spatial Platforms
    • AI and Machine Learning Integration Enhances Spatial Data Interpretation and Accelerates Biological Insight Generation
    • Rising Investment by Biopharma in Oncology, Neuroscience, and Immunology Applications Drives Commercial Uptake of Spatial OMICS
    • Emergence of Cloud-based Bioinformatics Solutions Unlocks Opportunities for Scalable Spatial Data Storage and Analysis
    • Growing Demand for Spatial Resolution in FFPE-compatible Assays Expands Clinical Research and Diagnostic Use Cases
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Spatial OMICS Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Spatial OMICS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Spatial OMICS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Spatial Transcriptomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Spatial Transcriptomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Spatial Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Spatial Genomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Spatial Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Spatial Proteomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for FFPE by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for FFPE by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Fresh Frozen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Fresh Frozen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Academic & Translational Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Academic & Translational Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Sample Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Sample Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Instrumental Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Instrumental Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Data Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Data Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Spatial OMICS Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 30: USA Recent Past, Current & Future Analysis for Spatial OMICS by Technology - Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Spatial OMICS by Technology - Percentage Breakdown of Value Sales for Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics for the Years 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Spatial OMICS by Sample Type - FFPE and Fresh Frozen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for Spatial OMICS by Sample Type - Percentage Breakdown of Value Sales for FFPE and Fresh Frozen for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Spatial OMICS by End-Use - Academic & Translational Research Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Spatial OMICS by End-Use - Percentage Breakdown of Value Sales for Academic & Translational Research Institutes and Pharma & Biotech Companies for the Years 2025 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for Spatial OMICS by Product - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: USA 6-Year Perspective for Spatial OMICS by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Spatial OMICS by Workflow - Sample Preparation, Instrumental Analysis and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA 6-Year Perspective for Spatial OMICS by Workflow - Percentage Breakdown of Value Sales for Sample Preparation, Instrumental Analysis and Data Analysis for the Years 2025 & 2030
  • CANADA
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Spatial OMICS by Technology - Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Canada 6-Year Perspective for Spatial OMICS by Technology - Percentage Breakdown of Value Sales for Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics for the Years 2025 & 2030
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Spatial OMICS by Sample Type - FFPE and Fresh Frozen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Canada 6-Year Perspective for Spatial OMICS by Sample Type - Percentage Breakdown of Value Sales for FFPE and Fresh Frozen for the Years 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Spatial OMICS by End-Use - Academic & Translational Research Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada 6-Year Perspective for Spatial OMICS by End-Use - Percentage Breakdown of Value Sales for Academic & Translational Research Institutes and Pharma & Biotech Companies for the Years 2025 & 2030
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Spatial OMICS by Product - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Canada 6-Year Perspective for Spatial OMICS by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2025 & 2030
    • TABLE 48: Canada Recent Past, Current & Future Analysis for Spatial OMICS by Workflow - Sample Preparation, Instrumental Analysis and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Canada 6-Year Perspective for Spatial OMICS by Workflow - Percentage Breakdown of Value Sales for Sample Preparation, Instrumental Analysis and Data Analysis for the Years 2025 & 2030
  • JAPAN
    • Spatial OMICS Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Spatial OMICS by Technology - Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan 6-Year Perspective for Spatial OMICS by Technology - Percentage Breakdown of Value Sales for Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics for the Years 2025 & 2030
    • TABLE 52: Japan Recent Past, Current & Future Analysis for Spatial OMICS by Sample Type - FFPE and Fresh Frozen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Japan 6-Year Perspective for Spatial OMICS by Sample Type - Percentage Breakdown of Value Sales for FFPE and Fresh Frozen for the Years 2025 & 2030
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Spatial OMICS by End-Use - Academic & Translational Research Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Japan 6-Year Perspective for Spatial OMICS by End-Use - Percentage Breakdown of Value Sales for Academic & Translational Research Institutes and Pharma & Biotech Companies for the Years 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Spatial OMICS by Product - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan 6-Year Perspective for Spatial OMICS by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2025 & 2030
    • TABLE 58: Japan Recent Past, Current & Future Analysis for Spatial OMICS by Workflow - Sample Preparation, Instrumental Analysis and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Japan 6-Year Perspective for Spatial OMICS by Workflow - Percentage Breakdown of Value Sales for Sample Preparation, Instrumental Analysis and Data Analysis for the Years 2025 & 2030
  • CHINA
    • Spatial OMICS Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 60: China Recent Past, Current & Future Analysis for Spatial OMICS by Technology - Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: China 6-Year Perspective for Spatial OMICS by Technology - Percentage Breakdown of Value Sales for Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics for the Years 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Spatial OMICS by Sample Type - FFPE and Fresh Frozen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China 6-Year Perspective for Spatial OMICS by Sample Type - Percentage Breakdown of Value Sales for FFPE and Fresh Frozen for the Years 2025 & 2030
    • TABLE 64: China Recent Past, Current & Future Analysis for Spatial OMICS by End-Use - Academic & Translational Research Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: China 6-Year Perspective for Spatial OMICS by End-Use - Percentage Breakdown of Value Sales for Academic & Translational Research Institutes and Pharma & Biotech Companies for the Years 2025 & 2030
    • TABLE 66: China Recent Past, Current & Future Analysis for Spatial OMICS by Product - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: China 6-Year Perspective for Spatial OMICS by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Spatial OMICS by Workflow - Sample Preparation, Instrumental Analysis and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China 6-Year Perspective for Spatial OMICS by Workflow - Percentage Breakdown of Value Sales for Sample Preparation, Instrumental Analysis and Data Analysis for the Years 2025 & 2030
  • EUROPE
    • Spatial OMICS Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Spatial OMICS by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 71: Europe 6-Year Perspective for Spatial OMICS by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 72: Europe Recent Past, Current & Future Analysis for Spatial OMICS by Technology - Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Europe 6-Year Perspective for Spatial OMICS by Technology - Percentage Breakdown of Value Sales for Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics for the Years 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Spatial OMICS by Sample Type - FFPE and Fresh Frozen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe 6-Year Perspective for Spatial OMICS by Sample Type - Percentage Breakdown of Value Sales for FFPE and Fresh Frozen for the Years 2025 & 2030
    • TABLE 76: Europe Recent Past, Current & Future Analysis for Spatial OMICS by End-Use - Academic & Translational Research Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Europe 6-Year Perspective for Spatial OMICS by End-Use - Percentage Breakdown of Value Sales for Academic & Translational Research Institutes and Pharma & Biotech Companies for the Years 2025 & 2030
    • TABLE 78: Europe Recent Past, Current & Future Analysis for Spatial OMICS by Product - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Europe 6-Year Perspective for Spatial OMICS by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Spatial OMICS by Workflow - Sample Preparation, Instrumental Analysis and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe 6-Year Perspective for Spatial OMICS by Workflow - Percentage Breakdown of Value Sales for Sample Preparation, Instrumental Analysis and Data Analysis for the Years 2025 & 2030
  • FRANCE
    • Spatial OMICS Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 82: France Recent Past, Current & Future Analysis for Spatial OMICS by Technology - Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: France 6-Year Perspective for Spatial OMICS by Technology - Percentage Breakdown of Value Sales for Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics for the Years 2025 & 2030
    • TABLE 84: France Recent Past, Current & Future Analysis for Spatial OMICS by Sample Type - FFPE and Fresh Frozen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: France 6-Year Perspective for Spatial OMICS by Sample Type - Percentage Breakdown of Value Sales for FFPE and Fresh Frozen for the Years 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Spatial OMICS by End-Use - Academic & Translational Research Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France 6-Year Perspective for Spatial OMICS by End-Use - Percentage Breakdown of Value Sales for Academic & Translational Research Institutes and Pharma & Biotech Companies for the Years 2025 & 2030
    • TABLE 88: France Recent Past, Current & Future Analysis for Spatial OMICS by Product - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: France 6-Year Perspective for Spatial OMICS by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2025 & 2030
    • TABLE 90: France Recent Past, Current & Future Analysis for Spatial OMICS by Workflow - Sample Preparation, Instrumental Analysis and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: France 6-Year Perspective for Spatial OMICS by Workflow - Percentage Breakdown of Value Sales for Sample Preparation, Instrumental Analysis and Data Analysis for the Years 2025 & 2030
  • GERMANY
    • Spatial OMICS Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Spatial OMICS by Technology - Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany 6-Year Perspective for Spatial OMICS by Technology - Percentage Breakdown of Value Sales for Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics for the Years 2025 & 2030
    • TABLE 94: Germany Recent Past, Current & Future Analysis for Spatial OMICS by Sample Type - FFPE and Fresh Frozen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Germany 6-Year Perspective for Spatial OMICS by Sample Type - Percentage Breakdown of Value Sales for FFPE and Fresh Frozen for the Years 2025 & 2030
    • TABLE 96: Germany Recent Past, Current & Future Analysis for Spatial OMICS by End-Use - Academic & Translational Research Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Germany 6-Year Perspective for Spatial OMICS by End-Use - Percentage Breakdown of Value Sales for Academic & Translational Research Institutes and Pharma & Biotech Companies for the Years 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Spatial OMICS by Product - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany 6-Year Perspective for Spatial OMICS by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2025 & 2030
    • TABLE 100: Germany Recent Past, Current & Future Analysis for Spatial OMICS by Workflow - Sample Preparation, Instrumental Analysis and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Germany 6-Year Perspective for Spatial OMICS by Workflow - Percentage Breakdown of Value Sales for Sample Preparation, Instrumental Analysis and Data Analysis for the Years 2025 & 2030
  • ITALY
    • TABLE 102: Italy Recent Past, Current & Future Analysis for Spatial OMICS by Technology - Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Italy 6-Year Perspective for Spatial OMICS by Technology - Percentage Breakdown of Value Sales for Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics for the Years 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Spatial OMICS by Sample Type - FFPE and Fresh Frozen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy 6-Year Perspective for Spatial OMICS by Sample Type - Percentage Breakdown of Value Sales for FFPE and Fresh Frozen for the Years 2025 & 2030
    • TABLE 106: Italy Recent Past, Current & Future Analysis for Spatial OMICS by End-Use - Academic & Translational Research Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Italy 6-Year Perspective for Spatial OMICS by End-Use - Percentage Breakdown of Value Sales for Academic & Translational Research Institutes and Pharma & Biotech Companies for the Years 2025 & 2030
    • TABLE 108: Italy Recent Past, Current & Future Analysis for Spatial OMICS by Product - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Italy 6-Year Perspective for Spatial OMICS by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Spatial OMICS by Workflow - Sample Preparation, Instrumental Analysis and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy 6-Year Perspective for Spatial OMICS by Workflow - Percentage Breakdown of Value Sales for Sample Preparation, Instrumental Analysis and Data Analysis for the Years 2025 & 2030
  • UNITED KINGDOM
    • Spatial OMICS Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 112: UK Recent Past, Current & Future Analysis for Spatial OMICS by Technology - Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 113: UK 6-Year Perspective for Spatial OMICS by Technology - Percentage Breakdown of Value Sales for Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics for the Years 2025 & 2030
    • TABLE 114: UK Recent Past, Current & Future Analysis for Spatial OMICS by Sample Type - FFPE and Fresh Frozen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 115: UK 6-Year Perspective for Spatial OMICS by Sample Type - Percentage Breakdown of Value Sales for FFPE and Fresh Frozen for the Years 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Spatial OMICS by End-Use - Academic & Translational Research Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK 6-Year Perspective for Spatial OMICS by End-Use - Percentage Breakdown of Value Sales for Academic & Translational Research Institutes and Pharma & Biotech Companies for the Years 2025 & 2030
    • TABLE 118: UK Recent Past, Current & Future Analysis for Spatial OMICS by Product - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 119: UK 6-Year Perspective for Spatial OMICS by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2025 & 2030
    • TABLE 120: UK Recent Past, Current & Future Analysis for Spatial OMICS by Workflow - Sample Preparation, Instrumental Analysis and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 121: UK 6-Year Perspective for Spatial OMICS by Workflow - Percentage Breakdown of Value Sales for Sample Preparation, Instrumental Analysis and Data Analysis for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Spatial OMICS by Technology - Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Europe 6-Year Perspective for Spatial OMICS by Technology - Percentage Breakdown of Value Sales for Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics for the Years 2025 & 2030
    • TABLE 124: Rest of Europe Recent Past, Current & Future Analysis for Spatial OMICS by Sample Type - FFPE and Fresh Frozen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of Europe 6-Year Perspective for Spatial OMICS by Sample Type - Percentage Breakdown of Value Sales for FFPE and Fresh Frozen for the Years 2025 & 2030
    • TABLE 126: Rest of Europe Recent Past, Current & Future Analysis for Spatial OMICS by End-Use - Academic & Translational Research Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of Europe 6-Year Perspective for Spatial OMICS by End-Use - Percentage Breakdown of Value Sales for Academic & Translational Research Institutes and Pharma & Biotech Companies for the Years 2025 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Spatial OMICS by Product - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe 6-Year Perspective for Spatial OMICS by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2025 & 2030
    • TABLE 130: Rest of Europe Recent Past, Current & Future Analysis for Spatial OMICS by Workflow - Sample Preparation, Instrumental Analysis and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 131: Rest of Europe 6-Year Perspective for Spatial OMICS by Workflow - Percentage Breakdown of Value Sales for Sample Preparation, Instrumental Analysis and Data Analysis for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Spatial OMICS Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 132: Asia-Pacific Recent Past, Current & Future Analysis for Spatial OMICS by Technology - Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 133: Asia-Pacific 6-Year Perspective for Spatial OMICS by Technology - Percentage Breakdown of Value Sales for Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics for the Years 2025 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Spatial OMICS by Sample Type - FFPE and Fresh Frozen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific 6-Year Perspective for Spatial OMICS by Sample Type - Percentage Breakdown of Value Sales for FFPE and Fresh Frozen for the Years 2025 & 2030
    • TABLE 136: Asia-Pacific Recent Past, Current & Future Analysis for Spatial OMICS by End-Use - Academic & Translational Research Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 137: Asia-Pacific 6-Year Perspective for Spatial OMICS by End-Use - Percentage Breakdown of Value Sales for Academic & Translational Research Institutes and Pharma & Biotech Companies for the Years 2025 & 2030
    • TABLE 138: Asia-Pacific Recent Past, Current & Future Analysis for Spatial OMICS by Product - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 139: Asia-Pacific 6-Year Perspective for Spatial OMICS by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2025 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Spatial OMICS by Workflow - Sample Preparation, Instrumental Analysis and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific 6-Year Perspective for Spatial OMICS by Workflow - Percentage Breakdown of Value Sales for Sample Preparation, Instrumental Analysis and Data Analysis for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 142: Rest of World Recent Past, Current & Future Analysis for Spatial OMICS by Technology - Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 143: Rest of World 6-Year Perspective for Spatial OMICS by Technology - Percentage Breakdown of Value Sales for Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics for the Years 2025 & 2030
    • TABLE 144: Rest of World Recent Past, Current & Future Analysis for Spatial OMICS by Sample Type - FFPE and Fresh Frozen - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 145: Rest of World 6-Year Perspective for Spatial OMICS by Sample Type - Percentage Breakdown of Value Sales for FFPE and Fresh Frozen for the Years 2025 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Spatial OMICS by End-Use - Academic & Translational Research Institutes and Pharma & Biotech Companies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of World 6-Year Perspective for Spatial OMICS by End-Use - Percentage Breakdown of Value Sales for Academic & Translational Research Institutes and Pharma & Biotech Companies for the Years 2025 & 2030
    • TABLE 148: Rest of World Recent Past, Current & Future Analysis for Spatial OMICS by Product - Instruments, Consumables and Software - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 149: Rest of World 6-Year Perspective for Spatial OMICS by Product - Percentage Breakdown of Value Sales for Instruments, Consumables and Software for the Years 2025 & 2030
    • TABLE 150: Rest of World Recent Past, Current & Future Analysis for Spatial OMICS by Workflow - Sample Preparation, Instrumental Analysis and Data Analysis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 151: Rest of World 6-Year Perspective for Spatial OMICS by Workflow - Percentage Breakdown of Value Sales for Sample Preparation, Instrumental Analysis and Data Analysis for the Years 2025 & 2030

IV. COMPETITION